Impact of race/ethnicity, donor and recipient age, and donor on survival after allogeneic transplant in the post-transplant cyclophosphamide era

Allogeneic hematopoietic cell transplantation (HCT) is a potentially curative treatment for hematologic malignancies, and outcomes have improved over time [ 1 ]. However, Hispanic and non-Hispanic Black (NHB) patients have worse overall survival (OS) compared to non-Hispanic White (NHW) patients and are less likely to utilize an unrelated HCT donor [ 2 , 3 ], but this difference has not been evaluated in the post-transplant cyclophosphamide (PTCy) era. PTCy reduces GvHD and allows for increased availability of alternative allogeneic donors in minority patients [ 4 ].

Authors

Institutions

Publication Details

Journal
Blood Cancer Journal
Published
2026-11-17
DOI
https://doi.org/10.1038/s41408-026-01670-0
Primary Topic
Hematopoietic Stem Cell Transplantation
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Impact of race/ethnicity, donor and recipient age, and donor on survival after allogeneic transplant in the post-transplant cyclophosphamide era

Theresa Hahn, Shernan G. Holtan, Nandita Khera, Nisha M. Nair et al.
4 links
Blood Cancer Journal
Hematopoietic Stem Cell Transplantation
article

Impact of race/ethnicity, donor and recipient age, and donor on survival after allogeneic transplant in the post-transplant cyclophosphamide era

Theresa Hahn, Shernan G. Holtan, Nandita Khera, Nisha M. Nair, Megan M. Herr
article en

Abstract

Allogeneic hematopoietic cell transplantation (HCT) is a potentially curative treatment for hematologic malignancies, and outcomes have improved over time [ 1 ]. However, Hispanic and non-Hispanic Black (NHB) patients have worse overall survival (OS) compared to non-Hispanic White (NHW) patients and are less likely to utilize an unrelated HCT donor [ 2 , 3 ], but this difference has not been evaluated in the post-transplant cyclophosphamide (PTCy) era. PTCy reduces GvHD and allows for increased availability of alternative allogeneic donors in minority patients [ 4 ].

Blood Cancer JournalVol. 16(1)
Roswell Park Comprehensive Cancer Center (US), Mayo Clinic Hospital (US)
Health Resources and Services Administration, National Heart, Lung, and Blood Institute, Office of Naval Research, National Cancer Institute, National Institute of Allergy and Infectious Diseases
Good health and well-being, Reduced inequalities
Hematopoietic Stem Cell Transplantation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon